Low risk of SARS-CoV-2 in blood transfusion

M Owusu, AA Sylverken, P El-Duah, NK Ayisi-Boateng… - Plos one, 2021 - journals.plos.org
Background The novel coronavirus disease (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), continues to remain a global challenge …

COVID-19: Further evidence of no transfusion transmission

JR Luzzi, R Navarro, CL Dinardo - Transfusion and Apheresis Science, 2021 - trasci.com
SARS-CoV-2 pandemic had a huge impact on transfusion services, mostly due to the
shortage of blood donors during periods of intense social isolation and the implementation …

SARS-COV-2: is it a risk for blood transfusion?

DM Langhi, RC de Souza, M Barros… - … , Transfusion and Cell …, 2022 - SciELO Brasil
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human
coronavirus responsible for the coronavirus disease 2019 (COVID-19). The pandemic stage …

Severe acute respiratory syndrome coronavirus 2 and blood safety: an updated review

P Kiely, VC Hoad, CR Seed, IB Gosbell - Transfusion Medicine and …, 2022 - karger.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
human coronavirus first identified in late 2019 and subsequently declared a worldwide …

Automated SARS-COV-2 RNA extraction from patient nasopharyngeal samples using a modified DNA extraction kit for high throughput testing

H Al-Saud, K Al-Romaih, R Bakheet… - Annals of Saudi …, 2020 - annsaudimed.net
ABSTRACT BACKGROUND: The pandemic of severe acute respiratory syndrome
coronavirus 2 (SARS-COV-2) has prompted a need for mass testing to identify patients with …

Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency

P Kiely, VC Hoad, CR Seed, IB Gosbell - Vox Sanguinis, 2021 - Wiley Online Library
Background and Objective Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐
2) is a novel coronavirus, first identified in China at the end of 2019 and has now caused a …

Estimation of the number of blood donors during the COVID‐19 incubation period across China and analysis of prevention and control measures for blood transfusion …

Z Yuan, D Chen, X Chen, Y Wei - Transfusion, 2020 - Wiley Online Library
BACKGROUND The aim of this study was to estimate the number of blood donors during the
COVID‐19 incubation period across China. STUDY DESIGN AND METHODS In this study …

No evidence of SARS‐CoV‐2 transmission through transfusion of human blood products: A systematic review

WF Mawalla, BJ Njiro, GM Bwire, A Nasser… - EJHaem, 2021 - Wiley Online Library
The presence of viral nucleic material in the circulation poses a theoretical risk of
transmission through transfusion. However, little is known about the possibility of the actual …

[HTML][HTML] COVID-19 and blood safety: help with a dilemma

RY Dodd, SL Stramer - Transfusion medicine reviews, 2020 - ncbi.nlm.nih.gov
Many of us remember the extraordinary outbreak of Severe Acute Respiratory Syndrome
(SARS) in 2002 to 2003 and will recall the hurried responses to allay the possibility of …

[HTML][HTML] Detection of SARS-CoV-2 genome in stool and plasma samples of laboratory confirmed Iranian COVID-19 patients

M Makhmalbaf, SM Hosseini, HA Aghdaei… - Frontiers in Molecular …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARSCoV2), was first discovered in China in late 2019 and quickly spread …